RedHill Biopharma

About:

RedHill Biopharma specializes primarily in gastrointestinal and infectious diseases within the realm of specialty biopharmaceuticals.

Website: http://www.redhillbio.com

Twitter/X: RedHillBio

Top Investors: OrbiMed, Nomura, H. C. Wainwright & Co., Biomedical Advanced Research and Development Authority (BARDA), ROTH Capital Partners

Description:

RedHill Biopharma specializes in the field of gastrointestinal and infectious diseases, constituting its primary areas of focus within the realm of specialty biopharmaceuticals. It focuses on advancing gastrointestinal and infectious diseases management through innovation, dedication, and a collective mindset of delivering on its promises.

Total Funding Amount:

$275M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Tel Aviv, Tel Aviv, Israel

Founded Date:

2009-01-01

Contact Email:

info(AT)redhillbio.com

Founders:

Dror Ben-Asher, Ori Shilo

Number of Employees:

101-250

Last Funding Date:

2024-10-14

IPO Status:

Public

Industries:

© 2025 bioDAO.ai